Delivery Order SPE2DE24D0013-SPE2D626F9530
- Not listed
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $20.4K firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with a completion date of September 25, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with performance to be executed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain function) awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The award reflects Cepheid's specialized expertise in providing rapid molecular diagnostic testing for...
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a delivery order valued at $2,040 on October 24, 2025, for XPCOV2/FLU/RSV-10 diagnostic products, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at Cepheid's headquarters in Sunnyvale, California. The award represents a continuation of the agency's ongoing procurement of molecular diagnostic testing supplies and reagents...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $8,160 on October 28, 2025, for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of November 4, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This award utilizes no set-aside designation,...
- The U.S. Defense Logistics Agency awarded a $29,478.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025, with an ultimate completion date of August 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a relatively modest...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. for molecular diagnostic solutions under a firm fixed-price contract valued at $15,440, with an ultimate completion date of October 1, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, supports testing capabilities for COVID-19, influenza, and respiratory syncytial virus detection. The contract contains no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a for-profit...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 delivery order (4569923616) by the Defense Logistics Agency Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 12, 2025. The contract is for XPCOV2/FLU/RSV-10 diagnostic products—molecular testing reagents and cartridges for detecting COVID-19, influenza, and respiratory syncytial virus on the GeneXpert diagnostic platform. This is a firm fixed-price delivery order with no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F9530Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing supplies and reagents for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and reagents, with established relationships across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. This award was made without a set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement market. This delivery order supports the Defense Logistics Agency's Medical Supply Chain operations, which ensure the availability of critical medical supplies and diagnostic equipment across the Department of Defense healthcare system and other federal healthcare entities. Cepheid's diagnostic solutions, particularly its GeneXpert platform and associated molecular testing capabilities, provide rapid and accurate detection of infectious diseases critical to military medical readiness and federal healthcare operations. The company maintains substantial federal contracting capacity through multiple indefinite delivery contracts, including a $32.8 million vehicle with the Veterans Administration's VISN 6, positioning it as a reliable supplier for ongoing diagnostic testing requirements across the federal healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 11/4/25 |